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Abstract
Many Gram-negative pathogens possess virulence-related type III secretion systems. Salmonella enterica uses two of these
systems, encoded on the pathogenicity islands SPI-1 and SPI-2, respectively, to translocate more than 30 effector proteins
into eukaryotic host cells. SteA is one of the few effectors that can be translocated by both systems. We investigated the
conditions affecting the synthesis of this effector, its secretion to culture media and its translocation into host cells. Whereas
steA was expressed under a wide range of conditions, some factors, including low and high osmolarity, and presence of
butyrate, decreased expression. SteA was efficiently secreted to the culture media under both SPI-1 and SPI-2 inducing
conditions. The kinetics of translocation into murine macrophages and human epithelial cells was studied using fusions with
the 3xFLAG tag, and fusions with CyaA from Bordetella pertussis. Translocation into macrophages under non-invasive
conditions was mainly dependent on the SPI-2-encoded type III secretion system but some participation of the SPI-1 system
was also detected 6 hours post-infection. Interestingly, both type III secretion systems had a relevant role in the
translocation of SteA into epithelial cells. Finally, a deletion approach allowed the identification of the N-terminal signal
necessary for translocation of this effector. The amino acid residues 1–10 were sufficient to direct translocation into host
cells through both type III secretion systems. Our results provide new examples of functional overlapping between the two
type III secretion systems of Salmonella.
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Introduction
Many pathogenic Gram-negative bacteria rely on type III
secretion systems (T3SS) for their interaction with the host. A type
III secretion apparatus, also called injectisome or molecular needle
[1], is a complex structure, functionally and structurally related to
the flagella assembly system, consisting of at least 20 different
subunits, that spans the inner membrane, the periplasmic space,
and the outer membrane of the Gram-negative bacteria, and the
cell membrane of the host [2]. This system allows delivery into the
eukaryotic host cells of effector proteins that direct the different
stages of the infection at the cellular level.
Salmonella is a genus of Gram-negative bacteria that belongs to
the family Enterobacteriaceae. Salmonellae are facultative intra-
cellular parasites that can infect a wide variety of animals causing
different diseases, from localized intestinal infection to severe
systemic disease, depending on the Salmonella serovar and the host.
Salmonella enterica possesses two distinct T3SS, T3SS1 and T3SS2,
that are encoded by genes located in two different Salmonella
pathogenicity islands: SPI-1 and SPI-2, respectively. Function and
expression conditions for both systems are different (reviewed in
[3]). It is suggested that T3SS2 is a more recently acquired trait
because it is not present in another species of the genus: S. bongori
[4]. The T3SS1 is necessary for the invasion of non-phagocytic
cells [5,6], whereas the T3SS2 is induced after invasion and is
essential for survival and replication within macrophages [7].
However, some overlap exists and effectors from both systems are
involved in the biogenesis of the Salmonella-containing vacuole, a
modified phagosome that is the intracellular niche for this
pathogen [8,9,10,11] (reviewed in [12]).
More than 30 effectors can be translocated by T3SS1 or T3SS2
into the host cell [13]. They manipulate a number of key host
cellular functions, including signal transduction, membrane
trafficking and pro-inflammatory immune responses. The related
flagella system also contributes to virulence: aside from the effect of
flagellar-based motility in the invasiveness of Salmonella [14],
flagellin is translocated into the cytosol by the T3SS1 of Salmonella-
infected macrophages and results in activation of the inflamma-
some and caspase-1-mediated cell death (pyroptosis) [15,16,17].
Many Salmonella effectors are encoded inside SPI-1 or SPI-2.
Most of them are co-expressed with T3SS1 or with T3SS2 and are
secreted only through their cognate secretion system. Interestingly,
however, some of the effectors encoded outside the two main
islands are known to be secreted by both T3SS1 and T3SS2,
including SlrP [18,19,20], SopD [21], SpvC [22], SspH1 [23],
SteA, and SteB [24] (reviewed in [13]) and the recently identified
GtgE, SpvD, and SteE [25].
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Translocation of Salmonella effectors can be studied infecting
cultures of different cell lines. Invasive bacteria (expressing T3SS1)
are used to infect non-phagocytic cell lines, like epithelial human
HeLa cells. Phagocytic lines, like J774 and RAW264.7 macro-
phages, can also be infected in the same conditions but, since
invasive Salmonella trigger a rapid form of cell death called
pyroptosis in macrophages [26], infections of several hours
requires the use of non-invasive bacteria. Interestingly, the
expression of T3SS1 and T3SS2 and translocation of effectors
change with the conditions used for cultivation of bacteria before
infection, with the time post-infection, and with the host cell line
[27]. While fractionation and immunoblot with antibodies raised
against the effectors or against small tags can be used to analyze
translocation, an alternative is the generation of fusions with a
fragment of the gene cyaA from Bordetella pertussis encoding the
catalytic domain of a calmodulin-dependent adenylate cyclase.
This enzyme converts cellular ATP in cyclic AMP (cAMP) in the
presence of calmodulin. Because calmodulin is present in
eukaryotic host cells, but not in bacteria, translocation of one of
these fusions would be detected as an increase in the level of cAMP
in a culture of infected cells [28].
In vitro synthetic growth media can also be used to imitate, to
some extent, the in vivo environments. Secretion of effectors to the
supernatant of liquid bacterial cultures can then be analyzed by
immunoblot. Optimal expression of T3SS1 can be achieved at the
end of the exponential growth phase in bacteria cultured in rich
media with low aeration and high concentration of NaCl [29,30].
T3SS2 expression is obtained in acidic minimal media with low
phosphate and low magnesium concentration [29,31], conditions
found in the Salmonella containing vacuole. T3SS2-dependent
secretion can be increased by using strains lacking a complex of
SPI-2-encoded proteins SsaM, SpiC, and SsaL, or exposing wild-
type bacteria to pH 7.2 after growth at pH 5 [25,32].
SteA is a poorly characterized T3SS substrate that was
identified in a screen to find genes encoding effectors in S. enterica
serovar Typhimurium [24]. The screen was based on the CyaA
system described above. A library of translational fusions between
Salmonella chromosomal genes and a fragment of the gene cyaA
from B. pertussis was used to infect cultures of J774 macrophages.
When these cells were infected for 8 h under non-invasive
conditions (stationary-phase bacteria), translocation of SteA
depended on T3SS2. However, when using invasive bacteria,
SteA was also translocated in a T3SS1-dependent manner into
J774 infected for 1 h. A steA null mutant showed a three-fold
disadvantage in mouse spleen colonization. SteA localized to the
trans-Golgi network in both transfected and infected human
epithelial HeLa cells and to Salmonella-induced membrane tubules
containing trans-Golgi markers [24,33].
In this work we focus on SteA as a T3SS1 and T3SS2 effector
and we study the conditions that modulate its expression, its
secretion to culture media, and its translocation into eukaryotic
cells. In addition, we identify the sequences in SteA that are
important for secretion and translocation through both systems.
Results
Expression of steA under different conditions
SteA is one of the few T3SS Salmonella effectors that are secreted
by both T3SS1 and T3SS2. During infection Salmonella encounters
different environments that require the expression of one or the
other T3SS. Since both systems are optimally expressed in different
conditions, it was interesting to study the expression of steA in
relation with these conditions. For this purpose, two chromosomal
steA fusions were generated: a lacZ fusion, and a 3xFLAG fusion.
The lacZ fusion allowed the quantification of expression
measuring b-galactosidase activities (Fig. 1). The initial compar-
ison between cultures of the same strain grown overnight at 37uC
with low aeration in rich medium (LB) with 0.3 M NaCl or in
minimal medium with low phosphate, low pH, and low
magnesium (LPM, pH 5.8)), indicated that the expression of steA
was much higher in LPM (Fig. 1A). The first set of conditions
induces optimal expression of the SPI-1 [29,30] genes whereas
LPM mimics the environment that the bacteria find inside the
eukaryotic cells in the Salmonella-containing vacuole (SCV) and
induces the expression of the SPI-2 regulon [34]. This result
indicates that steA is optimally expressed in coordination with the
T3SS2. Key positive regulators of the expression of SPI-1 and SPI-
2 are the transcription factors HilA and SsrB, respectively. As seen
in Fig. 1A, the expression of steA was only slightly reduced by a hilA
mutation (measured under SPI-1-inducing conditions) or an ssrB
mutation (under SPI-2-inducing conditions).
Upon an oral infection Salmonella finds environmental conditions
including acidity, hyperosmolarity and hypoxia and these factors
regulate the expression of T3SS1 [35], therefore these conditions
were tested in vitro using the LB medium. The same factors were
also tested in LPM. High osmolarity and oxygen limitation are
used in vitro to induce expression of SPI-1 genes. Expression of
steA was induced in low oxygen (Fig. 1D and E) but was repressed
by high osmolarity (Fig. 1B and C) and this repression was not due
to osmotic shock, since the results were obtained in the presence of
1 mM proline used as osmoprotectant. SPI-1 genes are down-
regulated after Salmonella exposure to butyrate, which is one of the
fermentation products found in the intestine. The same is true for
steA (Fig. 1D and E). Most SPI-1 genes are presumably not
expressed in the stomach due to acidity whereas the increase of pH
in the intestine could induce their expression. Expression of steA,
however, was not affected by changes in pH between 5 and 8.4,
both in LB (Fig. 1D) or LPM (Fig. 1E). This result indicated that
pH is not one of the factors inducing higher expression of steA in
LPM. A general conclusion of these experiments is that some of
the conditions (but not all) that lead to increased expression of SPI-
1 genes also up-regulate steA.
The 3xFLAG fusion permitted detection of C-terminally tagged
SteA by Western blotting against the FLAG epitope. This fusion
was used to monitor the expression of steA at the protein level
(Fig. 2). The results partially confirmed those obtained with the lac
fusion: acidic pH slightly increased expression in LB with shaking,
but the highest expression was obtained in LB with low aeration
and in LPM (SPI-2 conditions). Good expression was also obtained
in SPI-1 conditions (cultures in LB 0.3 M NaCl, without aeration).
However, the optimal concentration of NaCl in LB cultures was
170 mM. It is interesting to note that the level of SteA protein
decreased both at high and low osmolarity, in contrast with the
results obtained with the lac fusion, suggesting some kind of post-
translational regulation.
Secretion of SteA to the culture media
Specific media and culture conditions have been used to attain
optimal expression of T3SS1 or T3SS2 and to study in vitro
secretion of different effectors using these systems. As previously
mentioned, overnight cultures in LB with 0.3 M NaCl, without
shaking (SPI-1 conditions), are optimal for expression of T3SS1,
whereas maximal expression of T3SS2 is obtained in LPM at
pH 5.8 (SPI-2 conditions). Secretion of SteA was tested in both
conditions using the strain bearing the SteA-3xFLAG fusion.
Culture supernatants were concentrated and analyzed by
Western blot using anti-FLAG antibodies. Secretion was
observed under both conditions (Fig. 3A and 3B) and, as
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expected, secretion under SPI-1 conditions was dependent on
T3SS1 since it was no longer observed in a prgH background
(PrgH is an essential component of T3SS1), and secretion under
SPI-2 conditions was dependent on T3SS2 since it was no longer
observed in a ssaV background (SsaV is an essential component of
T3SS2). It was recently reported that some T3SS2 effectors are
more efficiently secreted to the culture media from mutant strains
lacking a complex of SPI-2-encoded proteins SsaM, SpiC and
SsaL. In addition, wild-type bacteria exposed to pH 7.2 after
growth at acidic pH also showed increased secretion of these
effectors due to dissociation of the SsaM/SpiC/SsaL complex
[32]. On these grounds, we tried these conditions for secretion of
SteA, but neither of them improved secretion of this effector
through the T3SS2 (Fig. 3C and 3D).
Figure 1. Expression of steA in different conditions. Expression levels were monitored with a chromosomal steA::lacZ fusion. For optimal SPI-1-
inducing conditions, the S. enterica strains carrying the fusions were incubated overnight at 37uC without shaking in LB with 0.3 M NaCl. For optimal
SPI-2-inducing conditions, the same strains were incubated overnight at 37uC with shaking in LPM. Means and standard deviations from duplicate
experiments are represented. (A) b-galactosidase activities were measured in wild-type (wt) and hilA backgrounds from cultures in SPI-1-inducing
conditions, and in wild-type and ssrB backgrounds from cultures in SPI-2-inducing conditions. SPI-1 (B) or SPI-2-inducing (C) cultures with different
concentrations of NaCl were used to test the effect of osmolarity. 1 mM proline was added as osmoprotectant to prevent osmotic shock. The effects
of pH, oxygen limitation and butyrate (But) on the expression of steA were tested under SPI-1 (D) and SPI-2-inducing conditions (E).
doi:10.1371/journal.pone.0026930.g001
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Translocation of SteA into RAW264.7 macrophages
Next, we analyzed the kinetics of translocation of SteA into the
eukaryotic host cells using well-established cell lines. First, we
infected cultures of the murine macrophage-like cell line
RAW264.7 with three strains of Salmonella producing SteA-
3xFLAG: one strain otherwise wild type, a prgH mutant, and an
ssaV mutant. These bacteria were in non-invasive conditions
(grown at 37uC in LB with shaking for 24 h prior to infection) in
order to prevent induction of rapid death in the macrophages. 2 h,
6 h and 12 h post-infection, cells were lysed under mild conditions
and the eukaryotic cytosol was separated from other components
and intact bacteria (pellet) by centrifugation and filtration. The
Figure 2. Levels of SteA protein in different conditions. Extracts from an S. enterica serovar Typhimurium 14028 (wild-type strain) derivative
expressing 3xFLAG-tagged SteA were resolved by 4–15% gradient SDS-PAGE. Immunoblotting was performed with a monoclonal anti-FLAG antibody
(upper panels). The conditions tested were: LB with different pH, high or low oxygen (LB cultures with or without shaking, respectively), LB with
10 mM butyrate (But), SPI-1 conditions (LB with 0.3 M NaCl, 16 h at 37uC, without shaking), SPI-2 conditions (LPM pH 5.8), and LB with different
concentrations of NaCl, as indicated. Anti-GroEL antibodies were used as loading control (lower panels). Ponceau S red staining was used as loading
control when testing the effect of osmolarity since GroEL expression is affected by changes in NaCl concentration. Molecular mass markers, in KDa,
are indicated on the left.
doi:10.1371/journal.pone.0026930.g002
Figure 3. Secretion of SteA to the culture media. The presence of SteA-3xFLAG in cell lysates (from 108 cells) and culture supernatants (from
2.56108 cells) was analyzed by immunoblotting with anti-FLAG antibodies as described in the Materials and Methods section. The immunoblots were
probed for GroEL as a loading control for the cell lysates and to test unspecific leakage of proteins into the supernatants. All the strains used
produced a 3xFLAG version of SteA and were derivatives of the wild-type strain 14028 (wt), a prgH mutant (lacking the T3SS1) and an ssaV mutant
(lacking the T3SS2). Bacteria were grown at 37uC using the following conditions: (A) SPI-1 conditions (LB with 0.3 M NaCl, overnight without shaking);
(B) SPI-2 conditions (LPM pH 5.8, 24 h with shaking); (C) SPI-2 conditions followed by shifting to pH 7.2 and 1 h incubation; (D) SPI-2 conditions in an
ssaL background.
doi:10.1371/journal.pone.0026930.g003
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presence of SteA in the pellet and of translocated SteA in the
eukaryotic cytosol was investigated by immunoblot with anti-
FLAG antibodies (Fig. 4A). Both fractions were also analyzed
with anti-GroEL antibodies to have some measure of the survival
and growth of bacteria and to get a control for the purity of the
cytosol fraction. Anti-b-actin was used to control the relative
number of host cells that were present at each time point. As seen
in Fig. 4A, translocation of SteA was observed 6 h p.i. but was
maximal 12 h after infection. An ssaV mutation abolished
translocation 12 h p.i., indicating that in these conditions SteA
is translocated specifically through the T3SS2. The decreases in
the amount of b-actin observed in the infections with the wild-
type strain and, to a lesser extent, with the prgH mutant, were
indicative of the death of the infected cells. This was visually
confirmed under the microscope (not shown). In fact, 24 h post-
infection most of the cells infected with these strains were dead
and it was impossible to evaluate the translocation of SteA (not
shown). Translocation 6 h post-infection was only partially
suppressed in the ssaV background, suggesting the possibility of
some translocation through the T3SS1 in these conditions. In
order to test this possibility we decided to use a sensitive method
based on the generation of a fusion with the catalytic domain of
CyaA from Bordetella pertussis. This protein is a calmodulin-
dependent adenylate cyclase. Calmodulin is not present in
bacteria but, upon translocation of a CyaA fusion into the host
cell, the adenylate cyclase would be activated by host calmodulin
to catalyze the production of cyclic AMP (cAMP). Plasmid
pIZ1886 expressing a SteA-CyaA’ fusion was introduced in S.
enterica serovar Typhimurium wild-type strain 14028 and isogenic
prgH mutant (lacking T3SS1), ssaV mutant (lacking T3SS2), and
prgH ssaV double mutant (lacking both T3SS). These strains were
used to infect RAW264.7 cells and the translocation of SteA-
CyaA’ was monitored 6 h post-infection by measuring the level of
cAMP in the cell cultures (Fig. 4B). The results confirm a major
role for T3SS2 in the translocation of SteA under these
conditions but also support a role for T3SS1.
Translocation of SteA into HeLa epithelial cells
Immunoblot experiments similar to the experiments described
in the previous section were also carried out infecting human
epithelial HeLa cells. Since these cells are non-phagocytic,
bacteria were in invasive conditions (grown overnight in LB with
0.3 M NaCl without shaking) for these experiments. The
presence of SteA-3xFLAG in the pellet and the eukaryotic
cytosol was analyzed 50 min and 4.5 h post-infection with anti-
FLAG antibodies (Fig. 5A). Translocation to the host cytosol was
observed only in the wild-type background 4.5 h post-infection.
Results with anti-GroEL, indicating that this method was not
sensitive enough to detect bacterial proteins 50 min post-
infection, prompted us to use the CyaA system described above
to study translocation into HeLa cells. S. enterica serovar
Typhimurium wild-type strain 14028 and isogenic prgH mutant,
and ssaV mutant were used to infect HeLa cells under invasive
conditions and the translocation of SteA-CyaA’ was monitored
15 min, 50 min, 2 h, 4 h, 8 h and 16 h post-infection. As seen in
Fig. 5B, translocation from the wild-type strain was detected at
the same level from 15 min to 16 h post-infection. Translocation
of SteA into HeLa cells was dependent on the T3SS1, since
infections with the prgH mutant gave low levels of cAMP.
Surprisingly, the ssaV mutation significantly reduced translocation
15 min and 50 min post-infection, suggesting a role for T3SS2 at
this short time.
Figure 4. Translocation of SteA into RAW264.7 cells. (A)
RAW264.7 cells were infected with Salmonella strains expressing SteA-
3xFLAG that were derivatives of the wild-type strain (wt), the prgH
mutant (lacking T3SS1), or the ssaV mutant (lacking T3SS2). 2 h, 6 h and
12 h post-infection cells were lysed with 0.1% Triton and submitted to
centrifugation. The pellets and the filtered and concentrated superna-
tants (cytosol) were analyzed by immunoblotting. The membranes were
cut in three parts. The top was incubated with anti-GroEL antibodies as
a control of contamination of the cytosol fraction with non-secreted
bacterial proteins. The middle was incubated with antibodies against
the cytosolic protein b-actin to measure the number of eukaryotic cells
that was present in each condition. The bottom was incubated with
anti-FLAG antibodies to detect the SteA protein that was present in the
intracellular bacteria (pellet) and that was translocated into the cytosol
of the eukaryotic cells (cytosol). (B) Macrophages RAW264.7 were
infected with S. enterica serovar Typhimurium wild-type, prgH, ssaV, or
prgH ssaV mutant strains, all of them harboring the plasmid pIZ1886
that expresses full length SteA in fusion with the catalytic domain of
CyaA from B. pertussis. To analyze translocation, the level of cAMP was
measured 6 h post-infection as described in the Materials and Methods
section. It is expressed as % of the maximum level of cAMP that was
measured per intracellular bacterium.
doi:10.1371/journal.pone.0026930.g004
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Expression of steA and the T3SS2 genes during HeLa cells
infections
The results obtained in the previous section prompted us to
analyze the expression of steA and ssaV (as an indicator of the
synthesis of the T3SS2) in the context of the infection of HeLa
cells. Derivatives of the strain 14028 of S. enterica serovar
Typhimurium carrying steA::lacZ or ssaV::lacZ fusions, were grown
under SPI-1 inducing conditions (LB 0.3 M NaCl, low aeration).
Under these conditions, expression of steA was high although not
maximal, as seen above. Under the same conditions, as expected,
ssaV was not expressed (less than 6 Miller units). Interestingly, very
quickly after infection, expression increased three-fold for steA and
ten-fold for ssaV (Fig. 6), giving support to the involvement of
T3SS2 in the translocation of SteA at the beginning of the
infection of HeLa cells under invasive conditions.
Identification of secretion signals in SteA
In order to investigate the signals relevant for secretion of SteA
to the culture media, we generated several CyaA fusions expressed
from plasmids. Different N- and C-terminal truncations were
obtained and tested by immunoblotting with anti-CyaA antibod-
ies. Fig. 7 shows the results obtained under SPI-1-inducing
conditions. Fusions with the full-length protein and with fragments
1–20 and 1–10 were efficiently secreted. In contrast, the fusion
with the amino acids 16–210 of SteA was not secreted. These
results suggest that the signal necessary for secretion is contained in
the first 10 amino acids of SteA.
Analysis of translocation of SteA fragments into
macrophages
The different CyaA fusions used in the previous section for the
secretion experiments were also tested in experiments of
translocation into RAW264.7 cells. The results (data not shown)
were consistent with the results of the secretion experiments and
suggested that the first 10 amino acids of SteA were also sufficient
for translocation of this effector into the host cell.
Salmonella can enter phagocytic cells, like macrophages
RAW264.7, by two different mechanisms: invasion and phagocy-
Figure 5. Translocation of SteA into HeLa cells. (A) HeLa cells were infected with Salmonella strains expressing SteA-3xFLAG grown under SPI-1
(invasive) conditions and the cells were processed 50 min or 4.5 h post-infection. Immunoblotting was carried out using anti-GroEL (top) and anti-
FLAG (bottom) antibodies on the same membranes. (B) Translocation of SteA-CyaA into HeLa cells. HeLa cells were infected with S. enterica serovar
Typhimurium wild-type, prgH or ssaV mutant strains, harboring the plasmid pIZ1886 that expresses full length SteA in fusion with the catalytic
domain of CyaA from B. pertussis. To analyze translocation, the level of cAMP was measured 15 min, 50 min, 2 h, 4 h, 8 h and 16 h post-infection as
described in the Materials and Methods section. Data are expressed as % of the maximum cAMP level that was measured in this experiment.
doi:10.1371/journal.pone.0026930.g005
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tosis. Whereas invasion is T3SS1-dependent, phagocytosis is
carried out without the participation of any T3SS. Therefore,
different bacterial growth and infection conditions can be used to
monitor the relevance of T3SS1 and T3SS2 in the translocation of
SteA into phagocytic cells. Translocation of the CyaA fusions that
were secreted to the medium (Fig. 7) and translocated into
RAW264.7 (data not shown) was assessed in the mutants prgH and
ssaV that are T3SS1- and T3SS2-defective strains, respectively.
Translocation of the three fusions measured 1 h after infection of
macrophages with invasive bacteria was T3SS1-dependent
(Fig. 8A). Translocation of the same fusions measured 12 h after
infection of macrophages with non-invasive bacteria was T3SS2-
dependent (Fig. 8B). These results suggest that the same N-
terminal motif is recognized by both Salmonella T3SS.
Discussion
For an efficient secretion, the synthesis of one effector should be
coordinated with the expression of its cognate T3S apparatus.
Examples of this coordination are found in Salmonella enterica
[36,37], Shigella flexneri [38,39,40], and Yersinia enterocolitica [41].
This work focuses on the study of SteA, a Salmonella effector that
was poorly characterized. It was described in 2005 as being able to
translocate into macrophages J774 through T3SS1 and T3SS2
[24]. Since SteA is a Salmonella effector that can be secreted
through two different T3SS, it was especially interesting to study
expression, secretion and translocation of this effector under
different conditions favoring the use of one or the other T3S
apparatus.
Our results (Fig. 1 and Fig. 2) indicate that steA is expressed
under a wide range of conditions. This is consistent with the ability
of this effector to be secreted through two systems that are
expressed in different conditions. However, we have identified
particular factors that increase or decrease expression. A
comparison of different media showed that, in vitro, optimal
expression is obtained in LPM at pH 5.8, a media that imitates the
conditions found in the SCV and that is also optimal for the
synthesis of T3SS2. Expression of steA, however, was not
significantly affected by changes in pH between 5.0 and 8.4 in
LB with 0.3 M NaCl without aeration (Fig. 1D) or in LPM
(Fig. 1E). Bacteria grown in LB media with low aeration and high
osmolarity until the end of the exponential growth phase are
maximally invasive due to optimal expression of T3SS1. These
conditions however are not the best for expression of steA because,
although low aeration increases expression of this gene (Fig. 1D
and E), hyperosmolarity does the opposite (Fig. 1B and C). This is
not just a consequence of osmotic shock since the results were
obtained in the presence of proline as osmoprotector. In addition,
immunoblot experiments (Fig. 2) revealed that low osmolarity also
decreases the amount of SteA, in spite of the expression of the
translational steA-lacZ fusion. This result suggests that hypoosmo-
larity compromises the stability of the protein SteA. The
suboptimal expression of SteA in the media that provides optimal
invasivity may not be totally representative of the situation during
the infection, since culture media are not able to perfectly mimic
the in vivo conditions. In fact, our experiments measuring the level
of expression of steA in the course of the infection of HeLa cells
suggest that this expression significantly increases upon contact of
Figure 6. Expression of steA and the T3SS2 during infection of HeLa cells. HeLa cells were infected with S. enterica serovar Typhimurium
strains carrying a steA::lacZ fusion (left panel) or a ssaV::lacZ fusion (right panel) under invasive conditions. b-galactosidase activities were measured
before infection (t = 0) and 15, 50, 120, and 240 min after infection.
doi:10.1371/journal.pone.0026930.g006
Figure 7. Identification of the sequences necessary for
secretion of SteA. Derivatives of S. enterica serovar Typhimurium
strain 14028 carrying plasmids expressing full-length (1–210) or
different fragments of SteA in fusion with CyaA from B. pertussis
(numbers in brackets indicate aminoacids included) were grown under
SPI-1 inducing conditions. The presence of the CyaA fusions in cell
lysates (from 108 cells) and culture supernatants (from 2.56108 cells)
was analyzed by immunoblotting with anti-CyaA antibodies as
described in the Materials and Methods section (upper panels). Anti-
GroEL antibodies were used as loading control and to test unspecific
leakage of proteins into the supernatants (lower panels). Molecular
mass markers, in KDa, are indicated on the left.
doi:10.1371/journal.pone.0026930.g007
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Salmonella with the host cell and remains elevated several hours
post-infection (Fig. 6).
Another factor that decreases expression of steA is butyric acid
(Fig. 1 and Fig. 2). This is one of the organic acids that are
necessary to maintain the normal status of the intestinal epithelium
[42]. In fact, treatment with butyric acid decreases invasion and
colonization of cecal epithelial cells [43,44]. In a transcriptomic
analysis 19 genes were found to be down-regulated with butyrate
more than two-fold in S.enterica serovar Typhimurium and S.
enterica serovar Enteritidis, 17 of these genes localized to SPI-1 and
one of the other two genes was sopE2, a gene encoding a T3SS1
effector located outside the island [45]. In addition, the level of
SipA, another effector encoded outside SPI-1, is also reduced after
exposition to butyrate [46]. Therefore, in regard to butyrate, steA
behaves like many T3SS1 related genes.
We used culture media that are optimal for expression of either
T3SS1 (LB 0.3 M NaCl) or T3SS2 (LPM pH 5.8) to characterize
the secretion of SteA through these systems (Fig. 3). Efficient
secretion was detected in both media and the secretion was
dependent on the expected T3SS. It has been suggested that the
complex SsaM-SpiC-SsaL regulates secretion through T3SS2 so
that translocon proteins are secreted first and, once the translocon
pores has been assembled and the pH of the cytosol is detected, the
secretion of effectors begins [32]. As a consequence the effector
SseJ is not secreted to the culture media unless the experiment is
carried out in an ssaL background or the pH is shifted to 7.2 at the
end of the experiment. This effect has also been observed for other
effectors [25]. Our results, however, show that SteA can be
efficiently secreted in LPM at pH 5.8 in a wild-type background,
although a small increase in secretion can be observed in the ssaL
mutant.
T3SS1 is expressed at the beginning of the infection and is
important for invasion. T3SS2 is expressed inside the Salmonella
containing vacuole and is necessary for create and maintain an
intracellular niche for survival and proliferation of the bacteria.
However, as mentioned in the Introduction, some overlap exists
between both systems. Our experiments studying the kinetics of
translocation of SteA into eukaryotic host cells provide two
additional examples of this overlapping. First, non-invasive
Salmonella translocated SteA into RAW264.7 cells mainly through
T3SS2 and this is clearly seen 12 h post-infection when the ssaV
mutation completely abolishes translocation (Fig. 4A). However,
although translocation 6 h post-infection is mainly T3SS2-
dependent, some translocation is observed in the ssaV mutant.
That this translocation occurs through T3SS1 is confirmed
because the double mutant shows no translocation (Fig. 4B).
These results suggest that T3SS1 is expressed and is functional in
the translocation of effectors inside macrophages for a certain
period of time. The second example is observed in the experiments
of translocation into HeLa cells using invasive bacteria. To
interpret these experiments it should be taken into account that
these cells are non-phagocytic. Therefore, entry of Salmonella
depends on bacterial factors, mainly on the invasivity provided by
T3SS1. This is consistent with the results of the kinetics of
translocation into HeLa cells (Fig. 5B) showing that translocation is
T3SS1-dependent throughout the experiment, from 15 min to
16 h. In this context it is difficult to ascertain the role of T3SS2, if
any, in the translocation of effectors. Translocation for 4 h, 8 h
and 16 h is measured for bacteria inside de host cells, since
treatment with the antibiotic gentamicin is used to kill extracellular
cells. Therefore, the T3SS1-deficient mutant prgH, that cannot
enter the host cell, would not show translocation even if the
secretion occurred through a different system. For shorter times,
up to 2 h, extracellular bacteria are present in the protocol we
used (see Materials and Methods), and we can detect translocation
from outside the host cell through the cytoplasmic membrane.
Interestingly, we observed a preponderant role for T3SS2 in the
translocation of SteA into HeLa cells 15 min after the infection
that decreases 50 min post-infection and is no longer detected 2 h
Figure 8. Analysis of the translocation of fragments of SteA
under invasive and non-invasive conditions. RAW264.7 cells
grown in 24-well plates were infected with the wild-type, prgH, or ssaV
strains of S. enterica serovar Typhimurium expressing full-length SteA
(1–210) or SteA fragments 1–10 or 1–20 in fusion with the catalytic
domain of CyaA from B. pertussis. (A) Bacteria were grown for 16 h in LB
with 0.3 M NaCl at 37uC without shaking and cAMP was measured 1 h
post-infection. The results are expressed as % of the maximum level of
cAMP measured in the experiment. (B) Bacteria were grown for 24 h in
LB at 37uC with shaking and cAMP was measured 12 h post-infection.
The results are expressed as % of the maximum level of cAMP per
bacterium measured in the experiment.
doi:10.1371/journal.pone.0026930.g008
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post-infection (Fig. 5B). This result was unexpected for two
reasons:
(i) The bacteria were grown under invasive conditions that
prevent expression of T3SS2 genes. This repression was
confirmed using an ssa V::lacZ fusion (Fig. 6, right panel, time
0). However, as seen in Fig. 6, the expression of this fusion
increased very quickly during infection of Hela cells, which is
consistent with the translocation of SteA through this system
at the beginning of the infection. It has been previously
shown that SPI-1 and SPI-2 genes are expressed simulta-
neously inside HeLa cells [27]. It should be noted, however,
that the shorter time after infection analyzed in that report
was 2 h. Here, we show that ssaV is expressed as early as
15 min after infection of HeLa cells. This result increases a
growing body of evidence showing expression of SPI-2
immediately after the entry of the bacteria into the small
intestine and indicating that T3SS2 contributes to intestinal
colonization [47,48,49,50]. A very recent report suggests that
expression of SPI-2 before invasion of host cells reflects
transcriptional priming that is needed later for intracellular
survival [51]. Our results suggest that T3SS2 is not only
expressed but also functional in the secretion of at least the
effector SteA at that time.
(ii) Even if 15 min post-infection SteA can be translocated
through T3SS2, it is expected to be translocated also through
T3SS1. The kinetics of SteA translocation in the ssaV single
mutant suggested an irrelevant or minor contribution of
T3SS1 to translocation of SteA 15 min post-infection,
although translocation through T3SS1 increased with the
time (Fig. 5B, compare 15 min, 50 min, and 2 h). A feature
of T3SS is their ability to engage substrates in a certain order
[52,53,54,55,56,57,58,59]. A sorting platform has been
recently described for T3SS1 that ensures secretion of the
translocases before the effectors [60]. This hierarchy of
secretion could also extend to the establishment of an order
of secretion between effector proteins based on differential
affinities of the different effector-chaperone complexes. In
this context, our results suggest that SteA is secreted through
T3SS1 at a relatively late stage in the secretion process.
Another factor that can contribute to a low level of secretion
of SteA through T3SS1 at the beginning of the infection is
the fact that this protein, unlike other T3SS1 effectors, is also
a substrate of T3SS2.
In should be noted, however, that in the conditions discussed
above the detection of SteA in the host cytosol was also dependent
on T3SS1. This result could be a consequence of the role of this
system not only in translocation of proteins but also in host cell
binding [56,61].
Due to low sequence similarity and lack of common features
among different T3S signal sequences, attempts to use computa-
tional methods to identify these signals have only achieved limited
accuracy [62,63,64,65,66]. As a result, experimental approaches
based on the generation of fusions with truncated forms of effector
proteins are necessary. Previous studies with other effectors have
shown that some kind of secretion signal exists at the N-terminus
[67,68,69,70,71]. In addition, for T3SS1 effectors like InvJ and
SipB small sequences contained in the N-terminal 10 amino acids
are enough to mediate secretion through this system [72,73]. Our
experiments with truncated forms of SteA show that the N-
terminal 10 amino acids of this protein are sufficient to direct
secretion into culture media (Fig. 7) and translocation into
eukaryotic host cells (Fig. 8) although the N-terminal 20 amino
acids are necessary for optimal secretion and translocation, in
particular through the T3SS2.
Finally, the results obtained with prgH and ssaV mutants in
macrophages suggest that the same N-terminal signal is recognized
by T3SS1 and T3SS2 (Fig. 8). These results also support the idea
of the universality of the secretion signals recognized by these
systems. In fact, the ability of effectors from one species to be
translocated by the T3SS of another bacterial species has been
documented [74,75,76]. In addition, it has been shown that the N-
terminal secretion sequence of the Salmonella T3SS1 effectors SopE
and SptP can direct secretion through the related flagellar system
[77]. In these cases, translocation through T3SS1 requires a
chaperone-binding domain, located in the first 140 amino acids, in
addition to the N-terminal secretion sequence. Although the
existence of a similar chaperone mechanism for SteA cannot be
ruled out, our experiments show that the N-terminal signal located
in the first 10 amino acids is enough to direct specific translocation
into RAW264.7 cells through T3SS1 and T3SS2. Additional
experiments are needed to identify chaperones for SteA and the
cognate chaperone-binding domain in the effector, if they exist.
Materials and Methods
Bacterial strains, bacteriophages and strain construction
E. coli and S. enterica serovar Typhimurium strains used in this
study are described in Table 1. Salmonella strains derive from the
mouse-virulent strain ATCC 14028. Transductional crosses using
phage P22 HT 105/1 int201 [78] were used for strain construction
[79]. To obtain phage-free isolates, transductants were purified by
streaking on green plates [80]. Phage sensitivity was tested by
cross-streaking with the clear-plaque mutant P22 H5.
Bacterial culture
The standard culture medium for S. enterica was Luria-Bertani
(LB) broth. Solid LB contained agar 1.5% final concentration.
Antibiotics were used at the following concentrations: kanamycin
(Km), 50 mg ml21; chloramphenicol (Cm), 20 mg ml21; ampicillin
(Ap), 100 mg ml21. For SPI-1-inducing conditions, Salmonella
strains were grown overnight at 37uC in LB-0.3M NaCl medium
in static conditions. For SPI-2-inducing conditions, cells from
cultures in LB were washed and diluted 1:100 with minimal
medium at pH 5.8 (LPM) containing 80 mM 2-(N-morpholino)
ethanesulfonic acid (pH 5.8), 5 mM KCl, 7.5 mM (NH4)2SO4,
0.5 mM K2SO4, 0.1% casamino acids, 38 mM glycerol,
337.5 mM K2HPO4-KH2PO4 (pH 7.4) and 8 mM MgCl2, and
incubated overnight at 37uC with shaking. For some experiments
the concentration of NaCl or the pH of the medium were modified
as indicated. 10 mM sodium butyrate (Sigma) was added to the
medium in some experiments.
DNA amplification with the polymerase chain reaction
Amplification reactions were carried out in a Perkin Elmer
Gene-Amp PCR System 2400 (Perkin Elmer Cetus). The final
volume of reactions was 100 ml, and the final concentration of
MgCl2 was 1.5 mM. Reagents were used at the following
concentrations: dNTPs, 300 mM; primers, 0.3 mM; and Taq
polymerase (KAPA HiFi DNA Polymerase, Kapa Biosystems), 1
unit per reaction. The thermal program included the following
steps: (i) initial denaturation, 5 min at 95uC; (ii) 25 cycles of
denaturation (98uC, 20 s), annealing (57uC, 15 s), and extension
(72uC, 30 s); and (iii) final incubation at 72uC for 5 min, to
complete extension. Primers are listed in Table 2. PCR constructs
were sequenced with an automated DNA sequencer (Stab Vida,
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Table 1. Bacterial strains and plasmids used in this study.
Strain/Plasmid Relevant characteristics Source/Reference
E. coli
DH5a supE44 DlacU169 (Ø80 lacZDM15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1 [87]
TP610 F-, thi-1 thr-1 leuB6 lacY1 tonA21 supE44 hsdR hsdM recBC lop-11 lig+cya-610 [88]
S. enterica serovar Typhimurium
14028 Wild type ATCC
SV5846a 14028 steA::3xFLAG, Kmr This study
SV6152 14028 steA::lacZ This study
SV5379 14028 DprgH Laboratory stock
SV5136 14028 ssaV::Cmr Laboratory stock
SV5604 14028 DprgH ssaV::Cmr Laboratory stock
Plasmids
pKD13 bla FRT aph FRT PS1 PS4 oriR6K [83]
pKD46 bla PBAD gam bet exo pSC101 oriTS [83]
pCP20 bla cat cI857 lPR flp pSC101 oriTS [89]
pCE40 aph FRT ‘lacZ lacY+ this oriR6K [84]
pSIF003-R1 pEX-CyaA1–412 derivative [81]
pIZ1673 pSIF003-R1 DlacI This study
pIZ1886 pIZ1673-SteA This study
pIZ1889 pIZ1673-SteA(1–20) This study
pIZ1890 pIZ1673-SteA(1–10) This study
pIZ1891 pIZ1673-SteA(16–210) This study
aDerivatives of these strains were used as indicated in the text.
doi:10.1371/journal.pone.0026930.t001
Table 2. Oligonucleotides used in this study.
Oligonucleotide/use Sequence 59-39 (restriction sites are underlined)
Insertion in steA
steAP1 AACGCTTTTTAATAATTGTCCAAATAGTTATGGTAGCGAGGTGTAGGCTGGAGCTGCTTC
steAP4 TACTATAGATGTCGAGCTTTCTGATGGTCGGATGTTAACAATTCCGGGGATCCGTCGACC
Epitope tagging of SteA
steAP1flag CGACATAAAAGCTCGCTACCATAACTATTTGGACAATTATGACTACAAAGACCATGACGG
steAP2flag AGTCTGATTTCTAACAAAACTGGCTAAACATAAACGCTTTCATATGAATATCCTCCTTAG
Construction of pIZ1886
steAbampsif59 GAATGGATCCAGGAGGTAGGATATGCCATATACATCAGTTTC
steAbampsif39 CAAGGGATCCAATAATTGTCCAAATAGTTATG
Construction of pIZ1889
steAbampsif59 as above
steA20bampsif39 CAAGGGATCCAATGAGGTAGCTTATTTCCTG
Construction of pIZ1890
steAbampsif59 as above
steA10bampsif39 CAAGGGATCCAGGCATAGGTAGAAACTGATG
Construction of pIZ1891
steA16bampsif59 GAATGGATCCAGGAGGTCGACTATGAATAAGCTACCTCATGTTG
steAbampsif39 as above
Construction of pIZ1892
steA31bampsif59 GAATGGATCCAGGAGGTCGACTATGTCAACAAAAATCATGAAAG
steAbampsif39 as above
doi:10.1371/journal.pone.0026930.t002
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Oeiras, Portugal) to confirm that the sequence was correct (no new
sequencing data was generated in this work).
Plasmids
Plasmids used in this study are listed in Table 1. Plasmids
expressing CyaA’ fusions were derivatives of pIZ1673, a
modification of pSIF003-R1 [81] (a gift from I. Rosenshine, the
Hebrew University of Jerusalem) that was constructed by deletion
of the lacI gene using enzymes HpaI and SphI. Therefore,
expression of CyaA fusions from derivatives of pIZ1673 is no
longer dependent on IPTG. To construct these plasmids, DNA
from strain 14028 was used as a template for PCR amplification
with the primers listed in Table 2. The amplified fragments were
digested with BamHI and ligated with BamHI-digested and
dephosphorylated pIZ1673. To detect successful constructs
(plasmid with insert in the correct orientation), the ligation
mixture was transformed into E. coli TP610 and transformants
were selected in MacConkey agar supplemented with Ap and with
1% maltose. TP610 is a cya mutant strain [82] that can be
complemented with the basal adenylate cyclase activity that
possesses CyaA from B. pertussis in the absence of calmodulin.
Since cyaA in pIZ1673 does not harbor a start codon for
translation, transformants with empty plasmids or with inserts in
the wrong orientation give white colonies in MacConkey-maltose,
whereas plasmids with inserts in the correct orientation give red
colonies in the same medium.
Mammalian cell culture
HeLa cells (human epithelial; ECAC no. 93021013) and
RAW264.7 cells (murine macrophages; ECACC no. 91062702)
were cultured in DMEM supplemented with 10% foetal calf serum.
2 mM L-glutamine, 100 U ml21 penicillin, and 100 mg ml21
streptomycin were included in the culture media. All cells were
maintained in a 5% CO2 humidified atmosphere at 37uC.
Construction of a chromosomal lacZ fusion
Disruption and replacement of steA with a Km resistance gene
were performed as described previously [83]. Briefly, the Km
resistance gene from plasmid pKD13 was PCR amplified with
primers steAP1 and steAP4. The sequences of the primers used are
shown in Table 2. The PCR product was used to transform the
wild-type strain carrying the Red recombinase expression plasmid
pKD46. The antibiotic resistance cassette introduced by the gene-
targeting procedure was eliminated by recombination using the
FLP helper plasmid pCP20 [83]. The FRT site generated by
excision of the antibiotic resistance cassette was used to integrate
plasmid pCE40 to generate a translational lac fusion [84].
Chromosomal gene epitope tagging
Addition of a DNA fragment encoding the 3xFLAG epitope tag
at the 39 end of steA was carried out as described [85] using
primers SteA-P1Flag and SteA-P2Flag.
Western blotting and antibodies
Salmonella strains were grown under different conditions.
Usually, cultures in LB medium were diluted and grown in
different media. The bacteria were then pelleted by centrifugation
and resuspended in sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) sample buffer. Proteins from the
same numbers of bacteria were separated by gradient SDS-PAGE
(Mini-PROTEAN TGX precast gels, 4–15%) and electroforeti-
cally transferred to nitrocellulose filters for Western blot analysis
using anti-Flag M2 monoclonal antibodies (1:5000; Sigma), anti-
GroEL polyclonal antibodies (1:20000; Sigma) or anti-CyaA (3D1)
monoclonal antibodies (1:1000; Santa Cruz Biotechnology). Goat
anti-mouse HRP-conjugated antibodies (1:5000; BioRad) and goat
anti-rabbit HRP-conjugated antibodies (1:10000; GE Healthcare)
were used as secondary antibodies.
Protein secretion analysis
Salmonella strain SV5846 (14028 expressing SteA-3xFLAG) and
prgH or ssaV derivatives were grown in the different media
described above. For some experiments, strain 14028 carrying
plasmids pIZ1886, pIZ1889, pIZ1890, or pIZ1891, expressing
different fragments of SteA in fusion with CyaA from B. pertussis,
were grown under SPI-1-inducing conditions (LB 0.3 M NaCl,
overnight, without shaking). Whole cells and culture supernatants
were separated by centrifugation at 13000 g for 10 min. The
supernatants were filtered (0.45 mm pore-size) and incubated
30 min on ice with 0.02% deoxycholate. Proteins were then
precipitated by adding trichloroacetic acid at a final concentration
of 10% v/v, followed by incubation at 220uC for 5 min, on ice for
15 min and centrifugation (13000 g, 4uC, 15 min). The superna-
tant was discarded and the pellet was incubated with 300 ml of
cold acetone, 15 min on ice. After a new centrifugation step, the
pellet and the whole cells were processed for electrophoresis and
Western blot.
Bacterial infection of cultured cells
HeLa or RAW 264.7 cells were plated in 24-well plates at
1.56105 cells per well and incubated 24 h at 37uC with 5% CO2.
For the infection of HeLa cells under SPI-1 (invasive) conditions,
bacteria grown overnight in LB-0.3M NaCl in a tightly closed
tube without shaking were added at a multiplicity of infection
(MOI) of 150. The same conditions were used for infections of
macrophages RAW264.7 under invasive conditions except that
the MOI was 50. For infections of RAW264.7 under non-invasive
conditions, bacteria were grown in LB for 24 h at 37uC with
shaking and were added at a MOI of 250. Bacteria were
centrifuged onto the cell monolayer at 200 g for 5 min and then
incubated at 37uC with 5% CO2 for 15 min to 2 h. For longer
infections, the cell culture was washed twice with phosphate-
buffered saline (PBS) 1 h post-infection, overlaid with DMEM
containing 100 mg ml21 gentamicin, and incubated for another
hour. The culture was then washed twice with PBS, DMEM with
gentamicin 16 mg ml21 was added, and the culture was
incubated for another 2 to 14 h.
b-Galactosidase assays
Levels of b-galactosidase activity were assayed for stationary
phase cultures in LB medium or in minimal medium as described
[86], using the CHCl3/SDS permeabilization procedure. Enzy-
matic assays were also carried out during infection of HeLa cells.
The cell culture, infected as described above, was washed twice
with PBS, lysed with 1% Triton X-100 in 100 ml of PBS to release
intracellular bacteria. 100 ml of PBS were added and the whole
lysate was used for the b-galactosidase assay. The number of
bacteria in the assay was determined by plating serial dilutions
from a duplicate experiment and enumerating the colonies on the
following day. In order to calculate conventional Miller units, the
number of colony forming units was converted into the
corresponding value of OD600. This correspondence was
obtained by calculating OD600 and number of colony forming
units in the bacterial culture used in the infection. The b-
galactosidase activity of this culture was also measured and used as
time t = 0 in the experiment.
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Protein translocation assays
Following the infections described above, the translocation of
SteA fusions into the eukaryotic cells was monitored either by
immunoblot or by measuring the levels of cAMP. To study
translocation of 3xFLAG fusions, infected mammalian cells were
lysed with 0.1% Triton X-100. Cell lysates were centrifuged at
13000 g for 20 min at 4uC to separate the soluble fraction,
consisting of the host cell cytosol and translocated bacterial
proteins, from the insoluble fraction, containing the internalized
bacteria. The soluble fraction was filtered through a 0.22 mm pore-
size filter and subjected to TCA precipitation as described above.
Samples from both fractions were subjected to SDS-PAGE and
immunoblot using anti-FLAG antibodies. To study translocation
of CyaA fusions, the infected cells were lysed and the level of
cAMP in the lysates were determined using a colorimetric direct
cAMP enzyme immunoassay kit (Arbor Assays) according to the
manufacturer’s instructions. For experiments in RAW 264.7
macrophages infected for 6 h or 12 h, the levels of cAMP were
normalized to the number of intracellular bacteria. Data are
represented as % of the maximum level of cAMP that was
measured in the experiment.
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